Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use?
- PMID: 12201860
- DOI: 10.1046/J.1524-4733.2002.55150.x
Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use?
Abstract
Introduction: Statistical analyses of data and making sense of medical data have received much attention in the medical literature, but nevertheless have caused confusion among practitioners. Each researcher provides a different method for comparing treatments. For example, when the end point is binary, such as disease versus no disease, the common measures are odds ratios, relative risk, relative risk reduction, absolute risk reduction, and the number needed to treat. The question faced by the practitioner is then: Which one will help me in choosing the best treatment for my patient?
Methods: The purpose of this paper is to illustrate, using examples, how each measure is used, what it means, and what are its advantages and disadvantages.
Results: Some pairs of measures present equivalent information. Furthermore, it is shown that different measures result in different impressions.
Conclusion: It is recommended that researchers report both a relative and an absolute measure and present these with appropriate confidence intervals.
Similar articles
-
Interpretation of absolute measures of disease risk in comparative research.Fam Med. 2007 Jun;39(6):432-5. Fam Med. 2007. PMID: 17549653
-
Improving the calculation of confidence intervals for the number needed to treat.Stud Health Technol Inform. 2000;77:29-32. Stud Health Technol Inform. 2000. PMID: 11187559
-
Evidence-based dermatology: number needed to treat and its relation to other risk measures.J Am Acad Dermatol. 2007 Apr;56(4):664-71. doi: 10.1016/j.jaad.2006.08.024. Epub 2006 Oct 27. J Am Acad Dermatol. 2007. PMID: 17367615 Review.
-
Clinical versus statistical significance: interpreting P values and confidence intervals related to measures of association to guide decision making.J Pharm Pract. 2010 Aug;23(4):344-51. doi: 10.1177/0897190009358774. Epub 2010 Apr 13. J Pharm Pract. 2010. PMID: 21507834 Review.
-
How to deal with measures of association: a short guide for the clinician.Cerebrovasc Dis. 2012;33(2):98-103. doi: 10.1159/000334180. Epub 2011 Dec 13. Cerebrovasc Dis. 2012. PMID: 22156574
Cited by
-
Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trial.Nat Commun. 2023 Nov 16;14(1):7413. doi: 10.1038/s41467-023-42712-6. Nat Commun. 2023. PMID: 37973806 Free PMC article. Clinical Trial.
-
Aggregation of type-2 diabetes, prediabetes, and metabolic syndrome in German couples.Sci Rep. 2024 Feb 5;14(1):2984. doi: 10.1038/s41598-024-53417-1. Sci Rep. 2024. PMID: 38316913 Free PMC article.
-
Benefits of ICU admission in critically ill patients: whether instrumental variable methods or propensity scores should be used.BMC Med Res Methodol. 2011 Sep 21;11:132. doi: 10.1186/1471-2288-11-132. BMC Med Res Methodol. 2011. PMID: 21936926 Free PMC article.
-
Model-based estimation of measures of association for time-to-event outcomes.BMC Med Res Methodol. 2014 Aug 9;14:97. doi: 10.1186/1471-2288-14-97. BMC Med Res Methodol. 2014. PMID: 25106903 Free PMC article.
-
Mental Well-Being in First Year Medical Students: A Comparison by Race and Gender: A Report from the Medical Student CHANGE Study.J Racial Ethn Health Disparities. 2015 Sep;2(3):403-13. doi: 10.1007/s40615-015-0087-x. J Racial Ethn Health Disparities. 2015. PMID: 26413458 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources